CAS 685506-42-7

1-(2-Methyl-5-(piperidin-1-ylsulfonyl)furan-3-yl)-3-phenylurea

CAS : 685506-42-7

1-(2-Methyl-5-(piperidin-1-ylsulfonyl)furan-3-yl)-3-phenylurea

Degré de pureté : 99%

Masse moléculaire : 363.44g/mol

Ref: 54-OR1074579

GSK 264220A

Produit contrôlé

CAS : 685506-42-7

Formule : C₁₇H₂₁N₃O₄S

Couleur et forme : Neat

Masse moléculaire : 363.431

Ref: TR-G797608

GSK264220A

CAS : 685506-42-7

GSK264220A is a small molecule that modulates the activity of lipases, enzymes involved in fatty acid metabolism. GSK264220A has been shown to activate lipases, which are expressed in cardiac and skeletal muscle cells. The activation leads to an increase in fatty acid uptake by the cell and increased cellular energy metabolism. GSK264220A also has antiviral effects, inhibiting replication of the human immunodeficiency virus (HIV). GSK264220A also inhibits lipid accumulation in low-density lipoproteins (LDL) and reduces cholesterol levels. As a result, it is a potential therapeutic agent for treating cardiovascular disease as well as cancer.

Formule : C₁₇H₂₁N₃O₄S

Degré de pureté : Min. 95%

Masse moléculaire : 363.43 g/mol

Ref: 3D-KCB50642

GSK 264220A

CAS : 685506-42-7

endothelial lipase and lipoprotein lipase inhibitor

Formule : C₁₇H₂₁N₃O₄S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 363.43

Ref: TM-T22816